SCHEMBL802299

SCHEMBL802299

CCSc1ncccc1C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
TDP1 Q9NUW8 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
P2RY1 P47900 2/20 0.36
P2RY2 P41231 1/20 0.36
P2RY14 Q15391 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
CA2 P00918 1/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
PTGS1 P23219 2/20 0.33
PTGS2 P35354 2/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13868023 0.87 ALDH1A1 (0.40) ALDH1A1KDM4ESMN1; SMN2NPC1TDP1
SCHEMBL8115818 0.85 ALDH1A1 (0.41) ALDH1A1KDM4ESMN1; SMN2NPC1GAA
SCHEMBL13990506 0.85 HSD11B1 (0.43) ALDH1A1KDM4ESMN1; SMN2NPC1TDP1
SCHEMBL12263923 0.83 TDP1 (0.39) ALDH1A1SMN1; SMN2NPC1TDP1NPSR1
SCHEMBL21166378 0.82 LMNA (0.37) ALDH1A1KDM4ESMN1; SMN2NPC1TDP1
SCHEMBL13990721 0.79 CYP1A2 (0.45) ALDH1A1KDM4ESMN1; SMN2NPC1TDP1
SCHEMBL12898216 0.78 KMT2A (0.39) ALDH1A1KDM4ENPC1TDP1NPSR1
SCHEMBL12048608 0.76 KDM4E (0.45) ALDH1A1KDM4ESMN1; SMN2NPC1NPSR1
SCHEMBL16334247 0.76 ALDH1A1 (0.45) ALDH1A1KDM4ESMN1; SMN2NPC1TDP1
SCHEMBL10834448 0.76 ALDH1A1 (0.45) ALDH1A1KDM4ESMN1; SMN2NPC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071517-A1 2-PYRIDINYLETHYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES BAYER SAS (FR) 2012-03-22 US disclosed
US-20080312435-A1 Imine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312435-A1 Imine Compound CNR1, CNR2, HRH4 ALDH1A1 2674/4885KDM4E 3386/4885SMN1; SMN2 1844/4885
US-20120071517-A1 2-PYRIDINYLETHYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES CYP1A2, CYP51A1, CYP3A5 ALDH1A1 831/4885KDM4E 501/4885SMN1; SMN2 3882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.